A Study to Assess the Efficacy and Safety of HMI-115 in Subjects with Endometriosis-Associated Pain

Recruiting

Phase 2

A Study to Assess the Efficacy and Safety of HMI-115 in Subjects with Endometriosis-Associated PainA Study to Assess the Efficacy and Safety of HMI-115 in Subjects with Endometriosis-Associated Pain

Sponsor:

Hope Medicine (Nanjing) Co., Ltd

Code:

NCT05101317

Conditions

Endometriosis

Eligibility Criteria

Sex: Female

Age: 18 - 49

Healthy Volunteers: Not accepted

Interventions

HMI-115

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Hope Medicine (Nanjing) Co., Ltd on 2024-09-19.